2nd Edition of International Cancer and Precision Oncology Conference

Advancements in oncology continue to create new possibilities for improving patient care through personalized medical approaches. The 2nd Edition of International Cancer and Precision Oncology Conference (ICPOC 2026) (Hybrid Event), scheduled for November 23–25, 2026, in Singapore and Online, offers a unique opportunity to explore these developments within an international scientific setting.
Cancer Conference brings together professionals involved in cancer investigation, clinical practice, biomedical innovation, healthcare management, and pharmaceutical research. The conference aims to facilitate the exchange of scientific knowledge while promoting collaborative initiatives that contribute to progress in oncology.
Attendees will have access to presentations covering precision therapeutics, cancer genomics, molecular medicine, targeted treatment design, biomarker applications, clinical research methodologies, and novel healthcare technologies. The Upcoming Oncology Conferences highlights the importance of integrating scientific discoveries into practical solutions that benefit patients and healthcare systems.
The conference program includes keynote addresses, invited talks, oral communications, poster exhibitions, and professional networking sessions. These activities encourage participants to discuss research outcomes, evaluate emerging trends, and identify opportunities for future cooperation.
Precision Oncology Conference welcomes contributions from universities, hospitals, research centers, healthcare organizations, and industry sectors. Through international participation and multidisciplinary engagement, the conference supports the continuous advancement of cancer science and precision medicine.
As oncology enters a new era of innovation, ICPOC 2026 provides an ideal platform for sharing expertise, building partnerships, and contributing to global efforts aimed at improving cancer diagnosis, treatment, and long-term patient care.